Compare RLMD & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | OXM |
|---|---|---|
| Founded | 2004 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 543.0M |
| IPO Year | 2012 | 1994 |
| Metric | RLMD | OXM |
|---|---|---|
| Price | $4.07 | $28.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $12.40 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 1.1M | 462.0K |
| Earning Date | 05-08-2026 | 06-10-2026 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ 4.25 |
| Revenue | $13,070.00 | ★ $1,477,834,000.00 |
| Revenue This Year | N/A | $2.85 |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | ★ N/A | $6.81 |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $1.47 | $28.20 |
| 52 Week High | $8.00 | $49.58 |
| Indicator | RLMD | OXM |
|---|---|---|
| Relative Strength Index (RSI) | 35.21 | 25.77 |
| Support Level | $3.99 | $28.20 |
| Resistance Level | $4.51 | $42.57 |
| Average True Range (ATR) | 0.21 | 1.51 |
| MACD | 0.02 | -0.57 |
| Stochastic Oscillator | 12.31 | 1.87 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.